A Drug Utilization Study of SEASONIQUE in Europe

Study identification

• EU PAS number:
  EUPAS25516
• Study ID:
  33794
• Official title and acronym:
  A Drug Utilization Study of SEASONIQUE in Europe
• DARWIN EU® study:
  No
• Study countries:
  Belgium

  France

  Italy
• Study description:
  This is an observational retrospective cohort study to characterize drug utilization patterns of SEASONIQUE in European countries. The study population will be identified from an existing European health care databases.
• Study status:
  Finalised

Research institutions and networks

Institutions

IQVIA

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 28/09/2017

Actual: 28/09/2017

Study start date

Planned: 15/01/2019

Actual: 15/01/2019

Date of final study report

Planned: 30/03/2020

Actual: 13/02/2020

Sources of funding

Pharmaceutical company and other private sector 

More details on funding

Theramex UK Ltd

Regulatory

• Was the study required by a regulatory body?:
  Yes
• Is the study required by a Risk Management Plan (RMP)?:
  EU RMP category 1 (imposed as condition of marketing authorisation)